These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11305599)

  • 21. Establishment of rat precision-cut fibrotic liver slice technique and its application in verapamil metabolism.
    Guo Y; Wang H; Zhang C
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):406-13. PubMed ID: 17439408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral tegafur/uracil.
    Wellington K; Goa KL
    Drugs Aging; 2001; 18(12):935-48; discussion 949-50. PubMed ID: 11888348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of S-1 capsule in patients with advanced gastric cancer].
    Liu HY; Ding L; Yu Y; Chu Y; Zhu H
    Yao Xue Xue Bao; 2012 Oct; 47(10):1363-9. PubMed ID: 23289150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation of tegafur magnetic long-circulating thermosensitive liposomes and its pharmacokinetics in rats].
    Zeng ZW; Wang XL; Zhou WH; Zhang YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1864-8. PubMed ID: 18971191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
    Dadashzadeh S; Javadian B; Sadeghian S
    Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
    Kim HJ; Choi JS
    Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur.
    Arias JL; López-Viota M; Gallardo V; Adolfina Ruiz M
    Drug Dev Ind Pharm; 2010 Jun; 36(6):744-50. PubMed ID: 20345283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-gastric performance and bioavailability study of a new per-oral bioadhesive Verapamil HCl matrix tablet in dogs.
    Yassin AE; Alkhaled F; al-Suwayeh S; Elkheshen S
    Boll Chim Farm; 2003 Sep; 142(7):285-9. PubMed ID: 14677272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.
    Mori Y; Hanada K; Mori T; Tsukahara Y; Hashiguchi M; Ogata H
    Biol Pharm Bull; 2001 Jul; 24(7):806-10. PubMed ID: 11456122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples.
    Brandsteterová E; Wainer IW; Tracy T
    Neoplasma; 1999; 46(4):207-11. PubMed ID: 10613599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats.
    Kobuchi S; Ito Y; Takamatsu D; Sakaeda T
    Eur J Pharm Sci; 2018 Oct; 123():452-458. PubMed ID: 30077713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
    Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
    Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharmacol Toxicol Methods; 2008; 57(3):212-9. PubMed ID: 18442930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effect of polyethylene glycol 400 on the nasal absorption of nicardipine and verapamil in the rat.
    Rahman M; Lau-Cam CA
    Pharmazie; 1999 Feb; 54(2):132-6. PubMed ID: 10084158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling cardiac uptake and negative inotropic response of verapamil in rat heart: effect of amiodarone.
    Sermsappasuk P; Abdelrahman O; Weiss M
    Pharm Res; 2007 Jan; 24(1):48-57. PubMed ID: 16969694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.